Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Study Comparing EG-1962 to Standard of Care Oral Nimodipine in Adults With Aneurysmal Subarachnoid Hemorrhage

Trial Profile

Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Efficacy and Safety Study Comparing EG-1962 to Standard of Care Oral Nimodipine in Adults With Aneurysmal Subarachnoid Hemorrhage

Discontinued
Phase of Trial: Phase III

Latest Information Update: 27 Jun 2018

At a glance

  • Drugs Nimodipine (Primary) ; Nimodipine
  • Indications Cerebral ischaemia; Subarachnoid haemorrhage
  • Focus Registrational; Therapeutic Use
  • Acronyms NEWTON 2
  • Sponsors Edge Therapeutics
  • Most Recent Events

    • 27 Jun 2018 According to the Edge Therapeutics media release, company expects to report the final analysis data from all 283 subjects from this study when the data are available later this year.
    • 27 Jun 2018 Results presented in the Edge Therapeutics media release.
    • 10 Apr 2018 This trial is completed in Germany.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top